Search research articles
Contact Us
Filters
Showing results (51-60 of 60) with videos related to
Page
of 6
Sort By:
You have reached the last page of results.
This site can display upto 60 results.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie
|
January 1, 1982
Inhibition of rat adenocarcinoma metastases by "Staphylococcus aureus" protein A
F M Cowan, D L Klein, G R Armstrong, et al.
Leukemia Research
|
January 1, 1984
Busulfan versus cyclophosphamide treatment in the early and late stages of granulocytic leukemia in guinea pigs
W H Evans, D A Miller, J W Pearson, et al.
Obstetrics and Gynecology
|
April 1, 1974
Nonimmunologic hydrops fetalis. Report of two cases
D F Turbeville, A P Killam, P C Davis, et al.
Journal of Cellular Physiology
|
October 1, 1993
Increased epidermal growth factor receptor in an estrogen-responsive, adriamycin-resistant MCF-7 cell line
B Dickstein, E M Valverius, K Wosikowski, et al.
Journal of the National Cancer Institute
|
January 18, 1995
Enhancement by recombinant human interferon alfa of the reversal of multidrug resistance by MRK-16 monoclonal antibody
W E Fogler, J W Pearson, K Volker, et al.
Journal of the National Cancer Institute
|
June 2, 1993
Restoration of interferon alpha potentiation of a recombinant ricin A chain immunotoxin following cytoreduction of xenografts of advanced ovarian tumors
J W Pearson, W E Fogler, K Volker, et al.
Journal of the National Cancer Institute
|
October 2, 1991
Reversal of drug resistance in a human colon cancer xenograft expressing MDR1 complementary DNA by in vivo administration of MRK-16 monoclonal antibody
J W Pearson, W E Fogler, K Volker, et al.
Cancer Research
|
October 1, 1990
Enhanced therapeutic efficacy against an ovarian tumor xenograft of immunotoxins used in conjunction with recombinant alpha-interferon
J W Pearson, E Hedrick, W E Fogler, et al.
Behring Institute Mitteilungen
|
May 1, 1984
Tumor models to investigate the therapeutic efficiency of immunomodulators
E Talmadge, B F Lenz, M S Collins, et al.
Journal of the National Cancer Institute
|
June 5, 1996
Enhancement of vincristine cytotoxicity in drug-resistant cells by simultaneous treatment with onconase, an antitumor ribonuclease
S M Rybak, J W Pearson, W E Fogler, et al.
Page
of 6
Search research articles
Search
Showing results (51-60 of 60) with videos related to
Sort By:
Page
of 6
You have reached the last page of results.
This site can display upto 60 results.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie
|
January 1, 1982
Inhibition of rat adenocarcinoma metastases by "Staphylococcus aureus" protein A
F M Cowan, D L Klein, G R Armstrong, et al.
Leukemia Research
|
January 1, 1984
Busulfan versus cyclophosphamide treatment in the early and late stages of granulocytic leukemia in guinea pigs
W H Evans, D A Miller, J W Pearson, et al.
Obstetrics and Gynecology
|
April 1, 1974
Nonimmunologic hydrops fetalis. Report of two cases
D F Turbeville, A P Killam, P C Davis, et al.
Journal of Cellular Physiology
|
October 1, 1993
Increased epidermal growth factor receptor in an estrogen-responsive, adriamycin-resistant MCF-7 cell line
B Dickstein, E M Valverius, K Wosikowski, et al.
Journal of the National Cancer Institute
|
January 18, 1995
Enhancement by recombinant human interferon alfa of the reversal of multidrug resistance by MRK-16 monoclonal antibody
W E Fogler, J W Pearson, K Volker, et al.
Journal of the National Cancer Institute
|
June 2, 1993
Restoration of interferon alpha potentiation of a recombinant ricin A chain immunotoxin following cytoreduction of xenografts of advanced ovarian tumors
J W Pearson, W E Fogler, K Volker, et al.
Journal of the National Cancer Institute
|
October 2, 1991
Reversal of drug resistance in a human colon cancer xenograft expressing MDR1 complementary DNA by in vivo administration of MRK-16 monoclonal antibody
J W Pearson, W E Fogler, K Volker, et al.
Cancer Research
|
October 1, 1990
Enhanced therapeutic efficacy against an ovarian tumor xenograft of immunotoxins used in conjunction with recombinant alpha-interferon
J W Pearson, E Hedrick, W E Fogler, et al.
Behring Institute Mitteilungen
|
May 1, 1984
Tumor models to investigate the therapeutic efficiency of immunomodulators
E Talmadge, B F Lenz, M S Collins, et al.
Journal of the National Cancer Institute
|
June 5, 1996
Enhancement of vincristine cytotoxicity in drug-resistant cells by simultaneous treatment with onconase, an antitumor ribonuclease
S M Rybak, J W Pearson, W E Fogler, et al.
Page
of 6